8-K - Picard Medical, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Picard Medical, Inc. issued a press release announcing its participation in the American College of Cardiology’s Annual Scientific Session & Expo (ACC.26) from March 28 to March 30, 2026, in New Orleans, Louisiana, featuring a poster presentation on its next-generation Emperor Total Artificial Heart and an exhibition booth #2554. This event highlights the company's SynCardia Total Artificial Heart and development progress to clinicians and researchers.

Key Takeaways

1Poster presentation titled 'THE EMPEROR TOTAL ARTIFICIAL HEART: A FULLY IMPLANTABLE, AUTOREGULATING SOLUTION FOR ADVANCED HEART FAILURE' on March 29, 2026, 11:00 a.m.–12:00 p.m., Hall E, presented by Duffy Elmer of SynCardia LLC.

2SynCardia exhibiting at booth #2554 during ACC.26 to discuss FDA-approved SynCardia Total Artificial Heart and Emperor platform.

3Picard Medical, Inc. (NYSE American: PMI) is parent of SynCardia Systems LLC, maker of the world's first total artificial heart approved by FDA and Health Canada.

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

. Regulation FD Disclosure. On March 20, 2026, Picard Medical, Inc. (the “Company”) issued a press release announcing that the Company will participate in the A

Regulation Fd

9.01

. Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 99.1 Picard Medical, Inc. Press Relea

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EXHIBIT 99.1